Hepatitis B virus Reactivation in patients with hepatocellular carcinoma undergoing anti-cancer therapy

Medicine and Dentistry

• Inpatient 100%
• Hepatocellular Carcinoma 100%
• Cancer Treatment 100%
• Hepatitis B Virus 100%
• Patient 45%
• Combination Therapy 18%
• Chemotherapy 18%
• Morbidity 18%
• Therapeutic Procedure 9%
• Neoplasm 9%
• Immunosuppressive Treatment 9%
• Cohort Effect 9%
• Complication 9%
• Pathogenesis 9%
• Chemotherapeutic Agent 9%
• Drug 9%
• Experience 9%
• Patient Characteristics 9%
• Hepatectomy 9%
• Antivirus Agent 9%
• Liver Cirrhosis 9%
• Antiviral Therapy 9%
• Ablation Therapy 9%
• Life Sustaining Treatment 9%